Text Size

Community Acquired Pneumonia in Telemark and Ostfold (CAPITO)

This study has been completed.
Sponsor:
Collaborator:
Sykehuset Ostfold
Information provided by:
Sykehuset Telemark
ClinicalTrials.gov Identifier:
NCT00467701
First received: April 30, 2007
Last updated: January 16, 2009
Last verified: January 2009
History of Changes
  Purpose

The aim of the study is to investigate the bacterial causes in community acquired pneumonia in adults admitted to hospital in two counties in Norway and to look at possible factors that makes the patients susceptible to pneumonia.


Condition
Community Acquired Pneumonia

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Prevalence of Legionella Infections, Bacterial Etiology in Pneumonia Among Patients Admitted to Hospital,- and Risk Factors/Characteristics for These Patients.(Translated From Norwegian)

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Sykehuset Telemark:

Biospecimen Retention:   Samples Without DNA

sputum


Enrollment: 380
Study Start Date: May 2007
Study Completion Date: February 2008
Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
Detailed Description:

In Norway there is little knowledge of which bacterias that causes pneumonia in patients admitted to hospital. There are also few registered cases of Legionnaires disease every year, compared to our neighbour countries.

Therefore 500 patients with community acquired pneumonia admitted to Telemark hospital and Ostfold hospital in Norway will be tested by urin antigen test for the detection of Legionella pneumophila serogroup 1 and Streptococcus pneumoniae. We will also perform routine bacterial culture of sputum and culture on medium for isolation of Legionella species. A throat swab from the patients will be tested for Mycoplasma pneumoniae, Chlamydophila pneumoniae and Bordetella pertussis using PCR-techniques. Legionella-serology will also be performed. In addition all the included patients are invited to fill in a questionnaire in order to look for risk factors for developing community acquired pneumonia.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients admitted to hospital with community acquired pneumonia.

Criteria

Inclusion Criteria:

  • Symptoms of lower airway infection and radiologic sings of pneumonia.

Exclusion Criteria:

  • Age<18
  • Serious psychiatric illness
  • Mentally retarded
  • Hospitalized last 14 days
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00467701

Locations
Norway
Sykehuset Telemark
Skien, Telemark, Norway, 3710
Sponsors and Collaborators
Sykehuset Telemark
Sykehuset Ostfold
Investigators
Study Chair: Halfrid Waage, dr.med Telemark Hospital, 3710 Skien, Norway
  More Information

No publications provided

Responsible Party: Wenche Røysted, Sykehuset Telemark HF, Norway
ClinicalTrials.gov Identifier: NCT00467701     History of Changes
Other Study ID Numbers: STHF 5690.10, NSD: 16388, REK: S-05393
Study First Received: April 30, 2007
Last Updated: January 16, 2009
Health Authority: Norway: Directorate of Health
Norway:National Committee for Medical and Health Research Ethics

Keywords provided by Sykehuset Telemark:
pneumonia
Legionnaires disease
risk factors

Additional relevant MeSH terms:
Bacterial Infections
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections

ClinicalTrials.gov processed this record on May 19, 2013